Claim Missing Document
Check
Articles

Found 4 Documents
Search

PEMBERIAN ASI PADA IBU DENGAN ANAK USIA 0-6 BULAN DI WILAYAH KERJA PUSKESMAS SUSUT I, KABUPATEN BANGLI PADA TAHUN 2017 Pande Agung Mahariski
E-Jurnal Medika Udayana Vol 7 No 9 (2018): Vol 7 No 9 (2018): E-Jurnal Medika Udayana
Publisher : Universitas Udayana

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (205.432 KB)

Abstract

Air susu ibu (ASI) merupakan makanan alami terbaik dengan kandungan yang dapat dicerna dengan baik untuk keperluan tumbuh kembang, kekebalan dan pencegahan terhadap penyakit menular dan tidak menular. Untuk menurunkan angka kematian dan kesakitan pada anak, WHO merekomendasikan air susu ibu diberikan secara eksklusif minimal selama 6 bulan. Pola menyusui eksklusif yang diberikan pada bayi berusia 5 bulan di Indonesia hanya 15,3% dengan pola menyusi parsial mencapai 83,2%. Cakupan pemberian ASI eksklusif pada bayi 0-6 bulan menurut provinsi Bali tahun 2014 adalah 72,2% namun belum mencapai target nasional yaitu 80%. Penelitian ini bertujuan untuk mengetahui pemberian ASI pada ibu dengan anak umur 0–6 bulan. Penelitian ini menggunakan rancangan penelitian deskriptif cross sectional dengan melibatkan 67 ibu menyusui di wilayah kerja Puskesmas Susut I tahun 2017. Data dikumpulkan dengan wawancara. Hasil penelitian didapatkan bahwa proporsi ibu yang memiliki anak usia 0–6 bulan yang memberikan ASI adalah 67,2%. Ibu menyusui eksklusif cenderung ditemukan pada ibu dengan usia >35 tahun (83,2%), pendidikan rendah (69,8%), tidak bekerja (68,8%), multipara (70,8%), pengetahuan ASI eksklusif cukup (68,8%), mendapat dukungan keluarga (69,2%), persalinan normal (68,1%), tempat kelahiran di bidan (83,3%), pemberi informasi ASI eksklusif oleh bidan (77,1%), mengerti informasi ASI eksklusif (83,8%), puas terhadap pelayanan tenaga kesehatan (70,7%) dan melakukan inisiasi menyusui dini (79,5%). Kesimpulan penelitian ini adalah ibu yang memberikan ASI saja sebesar 67,2%. Kata kunci: pola menyusui, ASI eksklusif, balita, ibu menyusui
What Are The Differences In Melasma Diagnosis And Management Across Diverse Ethnic Populations With Varying Skin Types? : A Systematic Review Juliave Dora Odheta Purba; Ketut Kwartantaya Winaya; Pande Agung Mahariski
The Indonesian Journal of General Medicine Vol. 13 No. 1 (2025): The Indonesian Journal of General Medicine
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/wxrcgp16

Abstract

Introduction: Melasma presents significant therapeutic challenges due to its varied presentation across diverse ethnic populations and skin types. There is a critical need for treatment strategies tailored to a patient's ethnic background and Fitzpatrick skin type to optimize efficacy while minimizing risks such as post-inflammatory hyperpigmentation (PIH), particularly in darker skin tones (Fitzpatrick III-V). Methods: This systematic review was conducted following PRISMA guidelines. A comprehensive search of PubMed, Semantic Scholar, Springer, and Sagepub databases was performed using a PICO-based strategy to identify studies on melasma diagnosis and management with respect to ethnic variations or skin types. Thirty studies met the inclusion criteria for final analysis. Results: The Melasma Area and Severity Index (MASI) was the most common diagnostic tool. Treatment efficacy varied significantly by population. In Indian cohorts, salicylic-mandelic acid peels and topical tranexamic acid were found to be safe and effective. Asian populations showed a preference for combination laser therapies, such as dual toning and picosecond lasers, to reduce the risk of rebound hyperpigmentation. Triple combination creams were effective in Middle Eastern skin , and non-hydroquinone alternatives demonstrated efficacy across multi-ethnic groups. High recurrence rates and PIH remain major challenges, especially in darker skin. Conclusion: The evidence confirms that a 'one-size-fits-all' approach to melasma is obsolete. Effective management requires a personalized strategy that considers the patient's ethnicity and skin phototype to balance efficacy with pigmentary safety. Combination therapies targeting multiple pathogenic pathways are superior , and the use of versatile agents like tranexamic acid alongside strict sun protection is crucial. Individualizing treatment is paramount for achieving sustained improvement and managing this chronic condition.
Glucocorticoid-induced hyperglycemia (GIH) in pemphigus vulgaris patient at Bangli District General Hospital: A case report Ni Kadek Setyawati; A. A. I. A. Nindya Sari; Pande Agung Mahariski
Bali Dermatology Venereology and Aesthetic Journal BDVJ - Vol. 2 No. 2 (December 2019)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/b53b1w20

Abstract

Background: Pemphigus vulgaris (PV) is an autoimmune disease characterized by mucocutaneous blistering and erosion. This is rare, but greatly affects the patient’s life quality and often cause complication of disease and therapy. Hyperglycemia is a complication due to steroid use called glucocorticoid-induced hyperglycemia (GIH). This case report describes hyperglycemia in PV treatment, which later can be a consideration of PV management. Case: A 44-year-old male patient complained of painful lesions on almost the whole body with a form of bullae, erosion, crusting, brittle, the Nikolsky sign (+), and Asboe-Hansen sign (+). The patient was diagnosed with PV. After he had supportive therapy and high-doses of methylprednisolone, his blood sugar is increased. Patients diagnosed by hyperglycemia state due to steroid use, then given insulin as therapy. The patient diagnosed with PV based on history taking and physical examination, but the histopathologic examination wasn’t done due to lack of modality at the hospital. The steroid was given as an immunosuppressive. Be the main therapy for PV, steroids lead hyperglycemia due to disruption of glucose metabolism, thereby increasing insulin resistance in tissues. The diagnosis of hyperglycemia due to steroid use is made in a patient with a normal sugar level before PV therapy. It occurred within the first 1-2 days of therapy. In these patients, diagnosis confirmed by increasing pre-prandial, 2 h post-prandial, and any-time glucose level, after two days methylprednisolone administration. Collaboration with internal medicine colleagues is needed. Conclusion: PV treatment with steroids can induce hyperglycemia, which is dangerous. The understanding mechanism is needed to make early detection and provide therapy properly.
Update on scrofuloderma Marianto; Hartono Kosim; Pande Agung Mahariski; Paulus Mario Christopher
Bali Dermatology Venereology and Aesthetic Journal BDVJ - Vol. 2 No. 2 (December 2019)
Publisher : Explorer Front

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51559/vygwv246

Abstract

Tuberculosis is one of the most significant diseases which causes death worldwide. TB infection is assumed to infect the lungs only from a general perspective. In fact, TB infection also causes lesions on the skin. Scrofuloderma, as one of the most common types of cutaneous tuberculosis, often misdiagnosed and managed improperly due to its similarity with abscess. In addition, there were still no national and international guidelines for scrofuloderma. This review to give insights and review about an update in the basic principle of scrofuloderma and management.